Fresenius Hikes FY26 Group Core EPS Guidance

11:07 PM EDT, 08/04/2026 (MT Newswires) -- Fresenius (FRE.F) increased its full-year 2026 guidance for core EPS growth, according to a Tuesday release. The therapy-focused healthcare company now expects group core EPS for the year to grow in the 10% to 15% range, compared with earlier projections of 5% to 10% in constant currency. Meanwhile, the company expects group organic revenue for the year to increase 4% to 7%.